We're All One Crisis Away from Taking Unlicensed Research Peptides
asteriskmag.com
1 thread
Summary:
1. takes unlicensed peptides, because the insurance declined to pay for what the doctor prescribed.
2. «“people generally don't try to quantify tail risks.” Among the people I talked to, this is true»
That’s a pretty bad outlook.
This is incredibly bad summary. If it were about prescription meds, they can be bought on gray market, problem solved.